A5113244726- HIV/AIDS drug development and treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Renal function and acid-base balance
- HIV/AIDS Research and Interventions
- HIV Research and Treatment
- HIV-related health complications and treatments
- Respiratory Support and Mechanisms
- Electrolyte and hormonal disorders
Bellvitge University Hospital
2024-2025
Institut d'Investigació Biomédica de Bellvitge
2024-2025
Universitat de Barcelona
2024
Hospital Clínic de Barcelona
2016
To assess the association between biomarkers of inflammation, coagulation and immune activation incidence non-AIDS-defining events in a contemporary, antiretroviral therapy (ART)-experienced virologically suppressed cohort people living with HIV (PLWH). Prospective, observational study. PLWH aged 30-70 years, undetectable viral load no history cardiovascular disease, randomly selected from outpatients were included. At baseline, plasma (high-sensitivity C-reactive protein [hs-CRP], sCD163,...
Introduction Antiretroviral therapy (ART) can be personalized through simple formulations with high resistance barriers, favorable safety profiles, and novel administration routes. Switching treatments has become a key clinical strategy for addressing drug toxicity interactions enhancing adherence convenience. This aims to improve the quality of life long-term efficacy, even in challenging cases like people living HIV (PLWH) multiple comorbidities, prior virological failure, resistance.